cx546 has been researched along with Cognition Disorders in 2 studies
1-(1,4-benzodioxan-6-ylcarbonyl)piperidine: structure in first source
Cognition Disorders: Disorders characterized by disturbances in mental processes related to learning, thinking, reasoning, and judgment.
Excerpt | Relevance | Reference |
---|---|---|
"Autism is a neurodevelopmental disorder in which the first diagnostic symptom is unusual reciprocal social interactions." | 1.39 | AMPAKINE enhancement of social interaction in the BTBR mouse model of autism. ( Crawley, JN; Gastrell, PT; Karras, MN; Oliver, CF; Silverman, JL, 2013) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Silverman, JL | 1 |
Oliver, CF | 1 |
Karras, MN | 1 |
Gastrell, PT | 1 |
Crawley, JN | 1 |
Lynch, G | 1 |
1 review available for cx546 and Cognition Disorders
Article | Year |
---|---|
Glutamate-based therapeutic approaches: ampakines.
Topics: Animals; Brain; Cognition Disorders; Dioxoles; Drug Evaluation, Preclinical; Excitatory Amino Acid A | 2006 |
1 other study available for cx546 and Cognition Disorders
Article | Year |
---|---|
AMPAKINE enhancement of social interaction in the BTBR mouse model of autism.
Topics: Animals; Autistic Disorder; Behavior, Animal; Cognition Disorders; Dioxoles; Disease Models, Animal; | 2013 |